Zepp Health Co. (NYSE:ZEPP) Short Interest Update

Zepp Health Co. (NYSE:ZEPP) saw a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 2,200 shares, a decrease of 46.3% from the February 29th total of 4,100 shares. Based on an average daily volume of 72,400 shares, the short-interest ratio is presently 0.0 days.

Wall Street Analysts Forecast Growth

Separately, Fundamental Research set a $4.96 price objective on Zepp Health and gave the stock a “buy” rating in a research report on Tuesday.

Institutional Trading of Zepp Health

A number of institutional investors have recently modified their holdings of ZEPP. Citadel Advisors LLC bought a new position in shares of Zepp Health during the third quarter worth about $30,000. Virtu Financial LLC acquired a new position in shares of Zepp Health during the fourth quarter valued at $33,000. Rhumbline Advisers increased its position in shares of Zepp Health by 791.3% during the 3rd quarter. Rhumbline Advisers now owns 30,215 shares of the company’s stock valued at $35,000 after purchasing an additional 26,825 shares during the period. Envestnet Asset Management Inc. boosted its position in shares of Zepp Health by 34.6% during the 2nd quarter. Envestnet Asset Management Inc. now owns 23,093 shares of the company’s stock valued at $43,000 after purchasing an additional 5,941 shares in the last quarter. Finally, Susquehanna International Group LLP grew its position in Zepp Health by 40.0% in the first quarter. Susquehanna International Group LLP now owns 40,094 shares of the company’s stock worth $53,000 after buying an additional 11,451 shares during the last quarter. Hedge funds and other institutional investors own 52.61% of the company’s stock.

Zepp Health Stock Performance

ZEPP stock traded up $0.01 during trading on Thursday, hitting $1.04. The company had a trading volume of 20,618 shares, compared to its average volume of 73,116. The firm has a market cap of $63.79 million, a PE ratio of -2.00 and a beta of 0.81. The firm has a 50-day moving average price of $1.23 and a 200-day moving average price of $1.27. Zepp Health has a 1-year low of $0.90 and a 1-year high of $2.10. The company has a quick ratio of 1.49, a current ratio of 2.04 and a debt-to-equity ratio of 0.34.

Zepp Health Company Profile

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals.